홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Pheniramine

HCID 4761
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
86-21-5
표준 SMILES
CN(C)CCC(c1ccccc1)c1ccccn1
InChIKey
IJHNSHDBIRRJRN-UHFFFAOYSA-N
분자식
C16H20N2
평균 분자량
240.34 g/mol
단동위원소 질량
240.16264865

개요

N,N-dimethyl-3-phenyl-3-(2-pyridinyl)-1-propanamine is a member of pyridines and a tertiary amino compound.

이름 및 식별자

우선 이름
Pheniramine
IUPAC
N,N-dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine
영어명
Pheniramine
분자식
C16H20N2
분자량
240.34

이름 및 동의어

pheniramineProphenpyridamineTripotonPyriton86-21-5PropheniramineFeniraminaPheniraminumdimethyl[3-phenyl-3-(pyridin-2-yl)propyl]amine2-(alpha-(2-Dimethylaminoethyl)benzyl)pyridineNSC-47965134FM9ZZ6M
이름 더 보기
AVILMetronTrimetonFeniramineNCI-C60695PHENIRAMINE BASE
2-Pyridinepropanamine, N,N-dimethyl-gamma-phenyl-DTXSID0023454Pyridine, 2-(alpha-(2-(dimethylamino)ethyl)benzyl)-dimethyl(3-phenyl-3-(pyridin-2-yl)propyl)amine(+-)-PheniramineRefChem:860603DTXCID203454D04AA16

데이터베이스 식별자

CAS
86-21-5
PubChem CID
4761
DTXSID
DTXSID0023454
ChEMBL
CHEMBL1193
ChEBI
CHEBI:91591
UNII
134FM9ZZ6M
EC Number
201-656-2
Nikkaji
J4.935B

물성

구조 계산 물성

XLogP
2.8
극성 표면적
16.1 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
2
회전 가능 결합 수
5
무거운 원자 수
18
형식 전하
0
복잡도
221

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Used in Switzerland
Solubility3.77e-01 g/L
Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Boiling Point175.00 °C. @ 25.00 mm Hg
Melting Point< 25 °C
Physical DescriptionSolid
Collision Cross Section156.75 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
108 °C · 108 °C
끓는 점
13 · bp13 181°; bp2 142°; bp0.5 135°
밀도
1.0081 · 1.0081
굴절률
25 · nD25 1.5519 to 1.5521
인화점
9.7 °C · 9.7 °C - closed cup
저장 조건
-20 °C · -20°C

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H300 (97.5%): Fatal if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 2 notifications to the ECHA C&L Inventory.

유해성 정보

Regulatory Information2-Pyridinepropanamine, N,N-dimethyl-.gamma.-phenyl-: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - 2-Pyridinepropanamine, N,N-dimethyl-.gamma.-phenyl-: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 2 (97.5%)

독성 정보

Effects During Pregnancy and Lactation◈ What is pheniramine?

안전 데이터

wgk
1
ridadr
UN1230 - class 3 - PG 2 - Methanol, solution
risk_code
11-23/24/25-39/23/24/25
hazard_code
F,T
safety_code
16-36/37-45
Hazard Classifications
Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralFlam. Liq. 2STOT SE 1
스토리지 클래스
3 - Flammable liquids

화학 및 산업

약리 정보

ATC Code · 4건

R - Respiratory system

D - Dermatologicals

QD - Dermatologicals

QR - Respiratory system

PharmacodynamicsPheniramine acts as an antagonist to allergic symptoms stemming from inappropriate histamine release to reduce edema, itching, and redness. The same antihistamine effect also produces sedation by acting in the central nervous system.
Mechanism of Action · 1건

Pheniramine competes with histamine for the histamine H1 receptor, acting as an inverse agonist once bound. The reduction in H1 receptor activity is responsible for reduced itching as well as reduced vasodilation and capillary leakage leading to less redness and edema. This can be seen in the suppression of the histamine-induced wheal (swelling) and flare (vasodilation) response. Inverse agonism of the H1 receptor in the CNS is also responsible for the sedation produced by first-generation antihistamines like pheniramine. The binding of pheniramine to H4 receptors, and subsequent inverse agonism, may also contribute to reduced itching by antagonizing inflammation.

Biological Half-LifeThe terminal half-life of pheniramine administered via IV is 8-17 h.
Metabolism/MetabolitesPheniramine undergoes N-dealkylation to N-didesmethylpheniramine and N-desmethylpheniramine.
MeSH Pharmacological Classification · 3건

Agents, usually topical, that relieve itching (pruritus).

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
용해도
클로로포름(약간 용해됨), DMSO(약간 용해됨), 메탄올(약간 용해됨)
물리적 상태
powder to crystal
산도 계수 (pKa)
4.03 · pKa 4.03± 0.08;9.32± 0.06(H2O,t undefined,I=0.30(NaCl)) (Uncertain)
색상
White to Almost white
주요 응용
임상 시험
InChI
1S/C16H20N2/c1-18(2)13-11-15(14-8-4-3-5-9-14)16-10-6-7-12-17-16/h3-10,12,15H,11,13H2,1-2H3
InChIKey
IJHNSHDBIRRJRN-UHFFFAOYSA-N
SMILES
CN(C)CCC(c1ccccc1)c2ccccn2
NIST
2 · Pyridine, 2[alpha-(2-dimethyl aminoethyl)benzyl](86-21-5)
Absorption, Distribution and Excretion · 2건

The administration of 30.5 mg of free base pheniramine resulted in a Cmax of 173-294 ng/mL with a Tmax of 1-2.5 h.

Pheniramine is eliminated by metabolism and via renal excretion. 24.3% of pheniramine is present in the urine as the parent drug.

Cellular LocationsMembrane
Metabolite PathwaysPheniramine H1-Antihistamine Action

용도 및 제조

Use Classification · 2건

Pharmaceuticals -> Dermatologicals -> Antihistamines

Pharmaceuticals -> Animal Drugs -> Approved in Taiwan

상·하류 제품 정보

상류 원료

Potassium amide2-벤질피리딘말레인산